A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients

B Benedetti
January 2010
Journal of Neurology, Neurosurgery & Psychiatry;Jan2010, Vol. 81 Issue 1, p26
Academic Journal
BACKGROUND: Diffusion tensor (DT) MRI enables quantification of the severity of brain and cervical cord pathology in multiple sclerosis (MS). OBJECTIVE: To investigate DT MRI patterns of cervical cord damage in patients with benign MS (BMS) and secondary progressive MS (SPMS), in order to achieve a better understanding of the mechanisms underlying the development of irreversible disability in MS. METHODS: Conventional and DT MRI scans of the cervical cord and brain were acquired from 40 BMS patients, 28 SPMS patients and 18 healthy individuals. Cervical cord and brain mean diffusivity (MD) and fractional anisotropy (FA) maps were created and average MD and FA were calculated. Cross sectional cord area (CSA) was also computed. RESULTS: 37 (92%) BMS patients and all (100%) SPMS patients had macroscopic cervical cord lesions. Compared with healthy individuals, BMS patients had higher average cord MD while SPMS patients had higher average cord MD, lower average cord FA and lower average CSA. Compared with BMS patients, SPMS patients had lower cord average FA and lower average CSA. In MS patients, Expanded Disability Status Scale (EDSS) was correlated with CSA (r = –0.47, p<0.0001), average cord FA (r = –0.37, p = 0.002) and brain T2 lesion volume (LV) (r = 0.34, p = 0.005). A multivariate regression model identified CSA, average cord FA and brain T2 LV as variables independently influencing the EDSS score (r = 0.58, p<0.0001). CONCLUSIONS: Cervical cord damage outside focal macroscopic lesions is limited in patients with BMS. The assessment of cord and brain pathology provides complementary information to improve the understanding of disability accumulation in MS.


Related Articles

  • MR correlates of cerebral atrophy in patients with multiple sclerosis. De Stefano, Nicola; Iannucci, Giuseppe; Sormani, Maria P.; Guidi, Leonello; Bartolozzi, Maria L.; Comi, Giancarlo; Federico, Antonio; Filippi, Massimo // Journal of Neurology;Aug2002, Vol. 249 Issue 8, p1072 

    Objective To investigate the in-vivo correlates of brain atrophy in patients with multiple sclerosis (MS) by assessing the relationship between normalized measures of brain volume (NBV) and other magnetic resonance (MR) measures of tissue damage. Background Brain atrophy diffusely occurs and...

  • Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis. Valentino, P.; Labate, A.; Nistic�, R.; Pirritano, D.; Cerasa, A.; Liguori, M.; Bastone, L.; Crescibene, L.; Quattrone, A. // Multiple Sclerosis (13524585);Jan2009, Vol. 15 Issue 1, p114 

    Objectives The aim of this study was to correlate the brain atrophy with serum levels of anti-GM1 antibodies in patients with relapsing-remitting multiple sclerosis (RRMS). Methods Plasma sample from 52 patients with RRMS and 65 healthy controls were examined for anti-GM1 antibodies. Patients...

  • Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis. Tan H M; Chan L L; Chuah K L; Goh N S S; Tang K K // British Journal of Radiology;Feb2004, Vol. 77 Issue 914, p153 

    The characteristic clinicoradiological findings of multiple sclerosis and acute disseminated encephalomyelitis (ADEM), demonstrating a recurrent progressive course in the former and monophasicity in the latter associated with multiple discrete white matter lesions with variable enhancement on...

  • The role of MRI in early diagnosis of MS. Whiting, Penny // GP: General Practitioner;6/23/2006, p26 

    The article discusses the role of MRI in early diagnosis of multiple sclerosis (MS). The diagnosis of MS is mainly clinical, based on identifying evidence of dissemination in both time and space. The time between a patient first experiencing symptoms and going on to have the second attack can...

  • Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective? Prosperini, Luca; Borriello, Giovanna; De Giglio, Laura; Leonardi, Laura; Barletta, Valeria; Pozzilli, Carlo // BMC Neurology;2011, Vol. 11 Issue 1, p26 

    Background: In daily clinical setting, some patients affected by relapsing-remitting Multiple Sclerosis (RRMS) are switched from the low-dose to the high-dose Interferon beta (IFNB) in order to achieve a better control of the disease. Purpose: In this observational, post-marketing study we...

  • Growing Region Segmentation Software (GRES) for quantitative magnetic resonance imaging of multiple sclerosis: intra- and inter-observer agreement variability: a comparison with manual contouring method. Parodi, Roberto C.; Sardanelli, Francesco; Renzetti, Paolo; Rosso, Elisabetta; Losacco, Caterina; Ferrari, Alessandra; Levrero, Fabrizio; Pilot, Alberto; Inglese, Matilde; Mancardi, Giovanni L. // European Radiology;Apr2002, Vol. 12 Issue 4, p866 

    Lesion area measurement in multiple sclerosis (MS) is one of the key points in evaluating the natural history and in monitoring the efficacy of treatments. This study was performed to check the intra- and inter-observer agreement variability of a locally developed Growing Region Segmentation...

  • Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. R H B Benedict // Journal of Neurology, Neurosurgery & Psychiatry;Feb2009, Vol. 80 Issue 2, p201 

    BACKGROUND: MRI research in multiple sclerosis (MS) samples reveals pathology in both the cerebral cortex and deep grey matter (DGM). The classical subcortical dementia hypothesis has been ascribed to MS and is supported by studies highlighting the role of thalamic atrophy in neuropsychological...

  • Pathology.  // Multiple Sclerosis (13524585);Sep2004 Supplement 2, Vol. 10, p153 

    This article presents summary of articles, related to the pathology of multiple sclerosis (MS). It is well known that MS is a demyelinating disease of the central nervous system. It is generally accepted that an important mechanism at myelin destruction is the immunologically mediated attack...

  • Prospects for the treatment of multiple sclerosis. Hughes, Richard A. C. // Journal of the Royal Society of Medicine;Feb1991, Vol. 84 Issue 2, p63 

    The article presents the author's comments on issues related to the treatment of multiple sclerosis. He argues that if a single viral or toxic cause of the disease could be found, it would be easier to find a cure or to produce a vaccine. It is suggested that there is a growing need to find a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics